Iproteos
Barcelona · Founded 2011
About Iproteos
Iproteos is a biotech company that focuses its activity on the R&D of new therapeutic strategies based on modulation of protein-ligand (PLI) and protein-protein interactions (PPIs) through peptidomimetics. The novel entities are obtained thanks to the IPRO technology, an innovative platform. Specifically, at Iproteos we apply the IPRO technology on the search for therapeutic agents for the treatment of diseases of the central nervous system (CNS). Based on our expertise in the field, Iproteos is your perfect partner in the discovery of potent and active peptidomimetics for your own targets.
Company Facts
- Founded: 2011
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Last round: Series Unknown (Oct 2016)
- Website: http://www.iproteos.com/
- Phone: +34934020906
Industries & Categories
Biotechnology, Chemical, Innovation Management
Social Profiles
Canonical: https://fsome.com/organization/iproteos-103561 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.